Superficial low grade and invasive high grade bladder cancer show very distinct characteristics in regard to molecular alterations (like FGFR3 or TP53 mutations) and clinical behavior and might represent different etiologic entities [17]. Here, FGFR3 is linked to urinary bladder cancer.